These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 2501198
41. Excretion of causative PCDFs congeners of Yusho by one year intake of FBRA in patients with Yusho. Nagayama J, Hirakawa H, Kajiwara J, Iida T, Todaka T, Uenotsuchi T, Shibata S, Tsuji H, Iwasaki T. Fukuoka Igaku Zasshi; 2007 May; 98(5):215-21. PubMed ID: 17642300 [Abstract] [Full Text] [Related]
42. [Average of the PCDFs value in blood in patients with Yusho in the 2001 to 2003 fiscal year and comparison between the clinical features and PCDFs]. Kanagawa Y, Matsumoto S, Tajima B, Uenotsuchi T, Shibata S, Furue M, Imamura T. Fukuoka Igaku Zasshi; 2007 May; 98(5):129-35. PubMed ID: 17642286 [Abstract] [Full Text] [Related]
43. [Differential correlation of medical/laboratory examinations with blood levels of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran in Yusho patients from 2001 to 2004]. Kanagawa Y, Matsumoto S, Akahane M, Koike S, Yoshimura T, Uchi H, Furue M, Imamura T. Fukuoka Igaku Zasshi; 2009 May; 100(5):166-71. PubMed ID: 19588845 [Abstract] [Full Text] [Related]
44. [Dermatological findings in the annual examination of the patients with Yusho in 1995-1996]. Nakayama J, Hori Y, Toshitani S, Asahi M. Fukuoka Igaku Zasshi; 1997 May; 88(5):236-9. PubMed ID: 9194349 [Abstract] [Full Text] [Related]
45. [Serum immunoglobulin concentrations and autoantibodies in patients with Yusho]. Tsuji H, Hirahashi T, Ogata H, Fujishima M. Fukuoka Igaku Zasshi; 1999 May; 90(5):147-9. PubMed ID: 10396868 [Abstract] [Full Text] [Related]
46. [Mitogen-induced lymphocyte transformation in patients with Yusho]. Tsuji H, Suzuki N, Sakisaka S. Fukuoka Igaku Zasshi; 2001 May; 92(5):112-4. PubMed ID: 11452506 [Abstract] [Full Text] [Related]
47. [Thyroid function in patients with Yusho]. Tsuji H, Ito Y. Fukuoka Igaku Zasshi; 2003 May; 94(5):103-7. PubMed ID: 12872709 [Abstract] [Full Text] [Related]
48. [Yearly and seasonal fluctuation of PCB concentration in skin surface lipid]. Watanabe M, Tanaka K, Toriyama F. Fukuoka Igaku Zasshi; 1997 May; 88(5):205-6. PubMed ID: 9194342 [Abstract] [Full Text] [Related]
49. Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event. Kanagawa Y, Matsumoto S, Koike S, Tajima B, Fukiwake N, Shibata S, Uchi H, Furue M, Imamura T. Environ Health; 2008 Oct 02; 7():47. PubMed ID: 18831733 [Abstract] [Full Text] [Related]
51. [Decreased serum aldolase levels in Yusho]. Yoshimura T, Nakano J, Kataoka H. Fukuoka Igaku Zasshi; 2007 May 02; 98(5):143-8. PubMed ID: 17642289 [Abstract] [Full Text] [Related]
52. [Congener specific determination of PCBs in human blood using gel permeation chromatography (GPC) and high resolution gas chromatography/high resolution mass spectrometry (HRGC/HRMS)]. Hori T, Tobiishi K, Ashizuka Y, Nakagawa R, Todaka T, Hirakawa H, Iida T. Fukuoka Igaku Zasshi; 2005 May 02; 96(5):220-6. PubMed ID: 15997777 [Abstract] [Full Text] [Related]
53. [Estimation of total antioxidant power in the serum of Yusho victims]. Shimizu K, Ogawa F, Sato S. Fukuoka Igaku Zasshi; 2007 May 02; 98(5):141-2. PubMed ID: 17642288 [Abstract] [Full Text] [Related]
54. [Relations between PCQ level and PCB pattern in the blood of yusho patients (author's transl)]. Takamatsu M, Oki M, Maeda K, Kashimoto T. Fukuoka Igaku Zasshi; 1981 Apr 02; 72(4):192-7. PubMed ID: 6793482 [No Abstract] [Full Text] [Related]
55. [Quantitative analysis of polychlorobiphenyl (PCB) and polychlorodibenzofuran (PCDF) isomers in the comedo and subcutaneous abscess of yusho patients]. Kuroki H, Ohma M, Haraguchi K, Masuda Y, Saruta T. Fukuoka Igaku Zasshi; 1987 May 02; 78(5):320-4. PubMed ID: 3117665 [No Abstract] [Full Text] [Related]
56. [Elevation of serum creatine kinase in the patients with Kanemi Yusho]. Yoshimura T, Okita M, Higashi T, Ueyama H, Ito H. Fukuoka Igaku Zasshi; 1997 May 02; 88(5):216-9. PubMed ID: 9194345 [Abstract] [Full Text] [Related]
57. [Laboratory findings in patients with Yusho: 26 year follow-up study]. Tsuji H, Ikeda K, Suzuki N, Fujishima M. Fukuoka Igaku Zasshi; 1995 May 02; 86(5):273-6. PubMed ID: 7628820 [Abstract] [Full Text] [Related]
58. [The difference between male and female dioxin concentrations in the blood of Yusho patients]. Kajiwara J, Todaka T, Hirakawa H, Hori T, Onozuka D, Takao Y, Hirata T, Iida T, Uchi H, Furue M. Fukuoka Igaku Zasshi; 2011 Apr 02; 102(4):140-4. PubMed ID: 21706894 [Abstract] [Full Text] [Related]
59. [Renal function in patients with yusho]. Murai K, Tsuji H, Fujishima M. Fukuoka Igaku Zasshi; 1989 May 02; 80(5):318-23. PubMed ID: 2501200 [Abstract] [Full Text] [Related]
60. [Evaluation of dermatological symptoms of Yusho patients in the annual examination in 2003-2004]. Uenotsuchi T, Furue M, Nakayama J, Asahi M, Kanagawa Y, Imamura T. Fukuoka Igaku Zasshi; 2005 May 02; 96(5):216-9. PubMed ID: 15997776 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]